Costs of treatment with biologic and targeted synthetic disease-modifying anti-rheumatic drugs in rheumatic diseases – data from the Romanian Registry of Rheumatic Diseases

Given the limited resources of the health system, rheumatologists are interested in reducing the costs of modern treatments for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis, given that the therapeutic targets are obtained and maintained. Data from the Romanian Registry of Rhe...

Full description

Bibliographic Details
Main Authors: Catalin Codreanu, Claudiu C. Popescu, Bogdan Baleanu, Corina Mogosan
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2020-03-01
Series:Romanian Journal of Rheumatology
Subjects:
Online Access:https://rjr.com.ro/articles/2020.1/RJR_2020_1_Art-04.pdf